Sacubitril and Valsartan

Product NDC
84386-082
11-digit product format
843860082
Labeler code
84386
Product ID
84386-082_ccfa182e-8a23-42e1-9062-be2655c96208
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Sacubitril and Valsartan
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Aurobindo Pharma Limited
Application
ANDA213631
Marketing category
ANDA
Marketing start
2026-10-26
Substance
SACUBITRIL; VALSARTAN
Active strength
49; 51 mg/1; mg/1
Pharmacologic classes
Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Neprilysin Inhibitor [EPC], Neprilysin Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A213631-001SACUBITRIL AND VALSARTANSACUBITRIL; VALSARTAN24MG;26MGTABLET / ORALAB2026-09-02
A213631-002SACUBITRIL AND VALSARTANSACUBITRIL; VALSARTAN49MG;51MGTABLET / ORALAB2026-09-02
A213631-003SACUBITRIL AND VALSARTANSACUBITRIL; VALSARTAN97MG;103MGTABLET / ORALAB2026-09-02

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-productTE code
A213631-001AB
A213631-002AB
A213631-003AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A213631-001SACUBITRIL AND VALSARTAN24MG;26MGTABLET / ORALAB2026-09-02d4dbc9d85df4…
2026-11-14 07:37:172026-10A213631-002SACUBITRIL AND VALSARTAN49MG;51MGTABLET / ORALAB2026-09-02d4dbc9d85df4…
2026-11-14 07:37:172026-10A213631-003SACUBITRIL AND VALSARTAN97MG;103MGTABLET / ORALAB2026-09-02d4dbc9d85df4…
2026-10-15 13:18:302026-09A213631-001SACUBITRIL AND VALSARTAN24MG;26MGTABLET / ORALAB2026-09-02c2088c7a36db…
2026-10-15 13:18:302026-09A213631-002SACUBITRIL AND VALSARTAN49MG;51MGTABLET / ORALAB2026-09-02c2088c7a36db…
2026-10-15 13:18:302026-09A213631-003SACUBITRIL AND VALSARTAN97MG;103MGTABLET / ORALAB2026-09-02c2088c7a36db…
2026-09-14 22:38:342026-08A213631-001SACUBITRIL AND VALSARTAN24MG;26MGTABLET / ORALAB2026-09-0284e616aacf4f…
2026-09-14 22:38:342026-08A213631-002SACUBITRIL AND VALSARTAN49MG;51MGTABLET / ORALAB2026-09-0284e616aacf4f…
2026-09-14 22:38:342026-08A213631-003SACUBITRIL AND VALSARTAN97MG;103MGTABLET / ORALAB2026-09-0284e616aacf4f…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A213631-001AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10A213631-002AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10A213631-003AB1d4dbc9d85df4…
2026-10-15 13:18:302026-09A213631-001AB1c2088c7a36db…
2026-10-15 13:18:302026-09A213631-002AB1c2088c7a36db…
2026-10-15 13:18:302026-09A213631-003AB1c2088c7a36db…
2026-09-14 22:38:342026-08A213631-001AB184e616aacf4f…
2026-09-14 22:38:342026-08A213631-002AB184e616aacf4f…
2026-09-14 22:38:342026-08A213631-003AB184e616aacf4f…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Sacubitril and Valsartan
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
SACUBITRIL49 mg/1
VALSARTAN51 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
17ERJ0MKGIInternal UNII lookup
80M03YXJ7IInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1656340Internal RxNorm lookup
1656349Internal RxNorm lookup
1656354Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
ccfa182e-8a23-42e1-9062-be2655c96208Available on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Sacubitril and ValsartanSACUBITRIL AND VALSARTANAurobindo Pharma Limitedccfa182e-8a23-42e1-9062-be2655c962082026-10-21Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 213631
application number: ANDA213631
ndc (product): 84386-082

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
84386-082-1884386008218180 TABLET, FILM COATED in 1 BOTTLE (84386-082-18) 2026-10-26NoNoCurrent
84386-082-608438600826060 TABLET, FILM COATED in 1 BOTTLE (84386-082-60) 2026-10-26NoNoCurrent
84386-082-788438600827810 BLISTER PACK in 1 CARTON (84386-082-78) / 10 TABLET, FILM COATED in 1 BLISTER PACK (84386-082-10) 10 blister pack2026-10-26NoNoCurrent